| abstract |
The invention relates to benzimidazole-carboxy compounds of 5-HT4 receptor agonists of formula (I) (see formula (I)), where R1 and X are as defined in the specification, or salts, solvates or stereoisomers of these acceptable for pharmaceutical use. The invention also relates to pharmaceutical compositions comprising said compounds, methods for using said compounds to treat diseases associated with 5-HT4 receptor activity, and processes and intermediates useful for preparing said compounds. In addition, the invention relates to crystalline forms of a compound of formula (I). |